Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906368 · ClinicalTrials.gov registry record · NA
Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension
A NA study, sponsored by Grace Lim, MD, MS.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05906368: Completed NA study, sponsored by Grace Lim, MD, MS.
NCT05906368 is a NA study that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906368, a NA study, has completed, sponsored by Grace Lim, MD, MS.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this pilot trial is to examine the feasibility and ease of use of monitoring by ClearSight in laboring and delivering patients with the intent to compare time-to-treatment of hypotension between conventionally monitored patients (Group CM) and those receiving HPI (Group CM + HPI) monitoring by ClearSight, in a population of healthy laboring women who receive epidural analgesia.
Primary Outcome
The difference in time between diagnosis of hypotension and treatment by clinical staff between CM and HPI groups
Interventions
- DIAGNOSTIC_TEST ClearSight HPI Monitoring system
- DIAGNOSTIC_TEST Standard of Care Blood Pressure Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2024-04-18 |
| Est. Completion | 2024-08-29 |
| Phase | NA |
What the finished NCT05906368 record still lists
NCT05906368 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which ClearSight HPI Monitoring system is the first listed.
NCT05906368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05906368 about?
NCT05906368 is a clinical study titled "Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension". The purpose of this pilot trial is to examine the feasibility and ease of use of monitoring by ClearSight in laboring and delivering patients with the intent to compare time-to-treatment of hypotension between conventionally monitored patients (Group CM) and those receiving HPI (Group CM + HPI) moni...
What is the current status of trial NCT05906368?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2024-04-18. Estimated completion is 2024-08-29.
What interventions are being tested in trial NCT05906368?
The interventions under investigation include: ClearSight HPI Monitoring system (DIAGNOSTIC_TEST), Standard of Care Blood Pressure Monitoring (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05906368?
This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05906368's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI